Skip to content
2000
Volume 26, Issue 14
  • ISSN: 1389-2010
  • E-ISSN: 1873-4316

Abstract

Background

Cisplatin (DDP) resistance remains a major challenge in the treatment of lung adenocarcinoma (LUAD). Autophagy is an important mechanism to generate drug resistance. It has been established that COL5A1 has been shown to accelerate LUAD metastasis and affect cellular processes.

Methods

We investigated the role of COL5A1 in DDP resistance using the H1299/DDP and A549/DDP cell lines. Flow cytometry, CCK8, and western blot assays were used to detect apoptosis, cell viability, and autophagy. In addition, upstream miRNAs were screened using bioinformatics methods. MS2-RIP assay and luciferase reporter gene assay were used to validate miRNA interaction with COL5A1. Transfection experiments and western blot experiments were performed to investigate miRNA targeting to COL5A1 and its regulation of autophagy through FSTL1. The role of miRNA and COL5A1 in LUAD cisplatin resistance was also verified .

Results

The down-regulation of COL5A1 significantly reduced the survival and autophagy of DDP-resistant cells while enhancing apoptosis. MiR-215-5p was found to be a direct regulator of COL5A1, which affects autophagy through FSTL1.

Conclusion

The present study demonstrated that miR-215-5p regulated COL5A1 to modulate FSTL1 and autophagy, thereby attenuating LUAD resistance to DDP. These findings deepen the understanding of LUAD pathogenesis and provide potential insights into therapeutic strategies.

Loading

Article metrics loading...

/content/journals/cpb/10.2174/0113892010303045240903053257
2024-09-16
2025-12-17
Loading full text...

Full text loading...

References

  1. SongJ. SunY. CaoH. LiuZ. XiL. DongC. YangR. ShiY. A novel pyroptosis-related lncRNA signature for prognostic prediction in patients with lung adenocarcinoma.Bioengineered20211215932594910.1080/21655979.2021.1972078 34488540
    [Google Scholar]
  2. YiM. LiA. ZhouL. ChuQ. LuoS. WuK. Immune signature-based risk stratification and prediction of immune checkpoint inhibitor’s efficacy for lung adenocarcinoma.Cancer Immunol. Immunother.20217061705171910.1007/s00262‑020‑02817‑z 33386920
    [Google Scholar]
  3. SuL. ZhaoJ. SuH. WangY. HuangW. JiangX. GaoS. CircRNAs in lung adenocarcinoma: Diagnosis and therapy.Curr. Gene Ther.20222211522 34856899
    [Google Scholar]
  4. KrisM.G HellmannM.D ChaftJ.E Chemotherapy for lung cancers: Here to stay.American Society of Clinical Oncology Educational BookASCO Publishers201410.14694/EdBook_AM.2014.34.e37524857127
    [Google Scholar]
  5. GuoS. BaiX. ShiS. LiS. LiuX. AnH. KangX. Multi-target tracheloside and doxorubicin combined treatment of lung adenocarcinoma.Biomed. Pharmacother.202215311339210.1016/j.biopha.2022.113392 35834992
    [Google Scholar]
  6. GhoshS. Cisplatin: The first metal based anticancer drug.Bioorg. Chem.20198810292510.1016/j.bioorg.2019.102925 31003078
    [Google Scholar]
  7. KaushalG.P. KaushalV. HerzogC. YangC. Autophagy delays apoptosis in renal tubular epithelial cells in cisplatin cytotoxicity.Autophagy20084571071210.4161/auto.6309 18497570
    [Google Scholar]
  8. LiangZ. ZhangT. ZhanT. ChengG. ZhangW. JiaH. YangH. Metformin alleviates cisplatin-induced ototoxicity by autophagy induction possibly via the AMPK/FOXO3a pathway.J. Neurophysiol.202112541202121210.1152/jn.00417.2020 33625942
    [Google Scholar]
  9. ZhuH. HuX. FengS. JianZ. XuX. GuL. XiongX. The hypoxia-related gene COL5A1 is a prognostic and immunological biomarker for multiple human tumors.Oxid. Med. Cell. Longev.2022202214210.1155/2022/6419695 35082969
    [Google Scholar]
  10. GongH. WuW. FangC. HeD. CircBFAR correlates with poor prognosis and promotes laryngeal squamous cell cancer progression through miR-31-5p/COL5A1 axis.Laryngoscope Investig. Otolaryngol.2022761951196210.1002/lio2.966 36544920
    [Google Scholar]
  11. FengG. MaH.M. HuangH.B. LiY.W. ZhangP. HuangJ.J. ChengL. LiG.R. Overexpression of COL5A1 promotes tumor progression and metastasis and correlates with poor survival of patients with clear cell renal cell carcinoma.Cancer Manag. Res.2019111263127410.2147/CMAR.S188216 30799953
    [Google Scholar]
  12. WangC. WangY. FuZ. HuangW. YuZ. WangJ. ZhengK. ZhangS. LiS. ChenJ. MiR-29b-3p inhibits migration and invasion of papillary thyroid carcinoma by downregulating COL1A1 and COL5A1.Front. Oncol.20221283758110.3389/fonc.2022.837581 35530352
    [Google Scholar]
  13. ChakrabortyS. NathD. A study on micrornas targeting the genes overexpressed in lung cancer and their codon usage patterns.Mol. Biotechnol.202264101095111910.1007/s12033‑022‑00491‑3 35435592
    [Google Scholar]
  14. LiuW. WeiH. GaoZ. ChenG. LiuY. GaoX. BaiG. HeS. LiuT. XuW. YangX. JiaoJ. XiaoJ. COL5A1 may contribute the metastasis of lung adenocarcinoma.Gene2018665576610.1016/j.gene.2018.04.066 29702185
    [Google Scholar]
  15. ChenY. ZhouY. HanF. ZhaoY. TuM. WangY. HuangC. FanS. ChenP. YaoX. GuanL. YuA.M. GonzalezF.J. HuangM. BiH. A novel miR-1291-ERRα-CPT1C axis modulates tumor cell proliferation, metabolism and tumorigenesis.Theranostics202010167193721010.7150/thno.44877 32641987
    [Google Scholar]
  16. SunF.B. LinY. LiS.J. GaoJ. HanB. ZhangC.S. MiR-210 knockdown promotes the development of pancreatic cancer via upregulating E2F3 expression.Eur. Rev. Med. Pharmacol. Sci.2018222486408648 30575904
    [Google Scholar]
  17. CaiY. AnB. YaoD. ZhouH. ZhuJ. MicroRNA miR-30a inhibits cisplatin resistance in ovarian cancer cells through autophagy.Bioengineered2021122107131072210.1080/21655979.2021.2001989 34747309
    [Google Scholar]
  18. SinghA. BhattacharyyaN. SrivastavaA. PruettN. RipleyR.T. SchrumpD.S. HoangC.D. MicroRNA-215-5p treatment suppresses mesothelioma progression via the mdm2-p53-signaling axis.Mol. Ther.20192791665168010.1016/j.ymthe.2019.05.020 31227395
    [Google Scholar]
  19. GaoJ.B. ZhuM.N. ZhuX.L. miRNA‐215‐5p suppresses the aggressiveness of breast cancer cells by targeting Sox9.FEBS Open Bio20199111957196710.1002/2211‑5463.12733 31538724
    [Google Scholar]
  20. Vychytilova-FaltejskovaP. MerhautovaJ. MachackovaT. Gutierrez-GarciaI. Garcia-SolanoJ. RadovaL. BrchnelovaD. SlabaK. SvobodaM. HalamkovaJ. DemlovaR. KissI. VyzulaR. Conesa-ZamoraP. SlabyO. MiR-215-5p is a tumor suppressor in colorectal cancer targeting EGFR ligand epiregulin and its transcriptional inducer HOXB9.Oncogenesis201761139910.1038/s41389‑017‑0006‑6 29199273
    [Google Scholar]
  21. WuK.L. TsaiY.M. LienC.T. KuoP.L. HungJ.Y. The roles of MicroRNA in lung cancer.Int. J. Mol. Sci.2019207161110.3390/ijms20071611 30935143
    [Google Scholar]
  22. LiuY.K. JiaY.J. LiuS.H. MaJ. FSTL1 increases cisplatin sensitivity in epithelial ovarian cancer cells by inhibition of NF-κB pathway.Cancer Chemother. Pharmacol.202187340541410.1007/s00280‑020‑04215‑9 33392640
    [Google Scholar]
  23. YangW. WuY. WangC. LiuZ. XuM. ZhengX. FSTL1 contributes to tumor progression via attenuating apoptosis in a AKT/GSK-3β – dependent manner in hepatocellular carcinoma.Cancer Biomark.2017201758510.3233/CBM‑170132 28655132
    [Google Scholar]
  24. JinT. ZhangY. ZhangT. MiR-524-5p suppresses migration, invasion, and emt progression in breast cancer cells through targeting FSTL1.Cancer Biother. Radiopharm.2020351078980110.1089/cbr.2019.3046 32298609
    [Google Scholar]
  25. BaeK. ParkK.E. HanJ. KimJ. KimK. YoonK.A. Mitotic cell death caused by follistatin-like 1 inhibition is associated with up-regulated Bim by inactivated Erk1/2 in human lung cancer cells.Oncotarget2016714180761808410.18632/oncotarget.6729 26716515
    [Google Scholar]
  26. YangM. LuZ. YuB. ZhaoJ. LiL. ZhuK. MaM. LongF. WuR. HuG. HuangL. ChouJ. GongN. YangK. LiX. ZhangY. LinC. COL5A1 Promotes the progression of gastric cancer by acting as a cerna of mir-137-3p to upregulate FSTL1 expression.Cancers20221413324410.3390/cancers14133244 35805015
    [Google Scholar]
  27. ShiL. CaoY. YuanW. GuoJ. SunG. Exosomal circRNA BTG2 derived from RBP-J overexpressed-macrophages inhibits glioma progression via miR-25-3p/PTEN.Cell Death Dis.202213550610.1038/s41419‑022‑04908‑4 35643814
    [Google Scholar]
  28. KimJ. KunduM. ViolletB. GuanK.L. AMPK and mTOR regulate autophagy through direct phosphorylation of Ulk1.Nat. Cell Biol.201113213214110.1038/ncb2152 21258367
    [Google Scholar]
  29. XieX. LiD. CuiY. XieT. CaiJ. YaoY. Decorin protects retinal pigment epithelium cells from oxidative stress and apoptosis via AMPK-mTOR-regulated autophagy.Oxid. Med. Cell. Longev.2022202211710.1155/2022/3955748 35391926
    [Google Scholar]
  30. WuX. XiaoY. ZhouY. ZhouZ. YanW. LncRNA FOXP4-AS1 is activated by PAX5 and promotes the growth of prostate cancer by sequestering miR-3184-5p to upregulate FOXP4.Cell Death Dis.201910747210.1038/s41419‑019‑1699‑6 31209207
    [Google Scholar]
  31. WangH. ChenJ. ZhangS. ZhengX. XieS. MaoJ. CaiY. LuX. HuL. ShenJ. ChaiK. ChenW. MiR-223 regulates autophagy associated with cisplatin resistance by targeting FBXW7 in human non-small cell lung cancer.Cancer Cell Int.202020125810.1186/s12935‑020‑01284‑x 32577098
    [Google Scholar]
  32. PiotrowskaA. WierzbickaJ. RybarczykA. TuckeyR. SlominskiA. ŻmijewskiM. Vitamin D and its low calcemic analogs modulate the anticancer properties of cisplatin and dacarbazine in the human melanoma A375 cell line.Int. J. Oncol.20195441481149510.3892/ijo.2019.4725 30968156
    [Google Scholar]
  33. ZangH. PengJ. WangW. FanS. Roles of microRNAs in the resistance to platinum based chemotherapy in the non-small cell lung cancer.J. Cancer20178183856386110.7150/jca.21267 29151973
    [Google Scholar]
  34. IslamM.A. SooroM.A. ZhangP. Autophagic regulation of p62 is critical for cancer therapy.Int. J. Mol. Sci.2018195140510.3390/ijms19051405 29738493
    [Google Scholar]
  35. TantaiJ. PanX. ChenY. ShenY. JiC. TRIM46 activates AKT/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells.Cell Death Dis.202213328510.1038/s41419‑022‑04727‑7 35354796
    [Google Scholar]
  36. DuH. LiY. SunR. YuanY. SunS. ZhangY. CEACAM6 promotes cisplatin resistance in lung adenocarcinoma and is regulated by microRNA-146a and microRNA-26a.Thorac. Cancer20201192473248210.1111/1759‑7714.13558 32648688
    [Google Scholar]
  37. ZhuC. XieY. LiQ. ZhangZ. ChenJ. ZhangK. XiaX. YuD. ChenD. YuZ. ChenJ. CPSF6-mediated XBP1 3’UTR shortening attenuates cisplatin-induced ER stress and elevates chemo-resistance in lung adenocarcinoma.Drug Resist. Updat.20236810093310.1016/j.drup.2023.100933 36821972
    [Google Scholar]
  38. MaR. WangC. WangJ. WangD. XuJ. miRNA–mRNA interaction network in non-small cell lung cancer.Interdiscip. Sci.20168320921910.1007/s12539‑015‑0117‑8 26338522
    [Google Scholar]
  39. WangM. LiaoJ. TanC. ZhouH. WangJ. WangK. LiY. WuW. Integrated study of miR‐215 promoting breast cancer cell apoptosis by targeting RAD54B.J. Cell. Mol. Med.20212573327333810.1111/jcmm.16402 33635591
    [Google Scholar]
  40. ZhaoJ. XuJ. ZhangR. SRPX2 regulates colon cancer cell metabolism by miR-192/215 via PI3K-Akt.Am. J. Transl. Res.2018102483490 29511442
    [Google Scholar]
  41. YangW. DuanQ. ZhuX. TaoK. DongA. Follistatin-like 1 attenuates ischemia/reperfusion injury in cardiomyocytes via regulation of autophagy.BioMed Res. Int.201920191810.1155/2019/9537382 31139662
    [Google Scholar]
  42. LiuT. LiuY. MillerM. CaoL. ZhaoJ. WuJ. WangJ. LiuL. LiS. ZouM. XuJ. BroideD.H. DongL. Autophagy plays a role in FSTL1-induced epithelial mesenchymal transition and airway remodeling in asthma.Am. J. Physiol. Lung Cell. Mol. Physiol.20173131L27L4010.1152/ajplung.00510.2016 28473327
    [Google Scholar]
/content/journals/cpb/10.2174/0113892010303045240903053257
Loading
/content/journals/cpb/10.2174/0113892010303045240903053257
Loading

Data & Media loading...


  • Article Type:
    Research Article
Keyword(s): autophagy; COL5A1; cytotoxicity; FSTL1; Lung adenocarcinoma; miR-215-5p
This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test